Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George E Johnson

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Environmental and Molecular Mutagenesis|December 4, 2019
Quantitative Interpretation of Genetic Toxicity Dose-Response Data for Risk Assessment and Regulatory Decision-Making: Current Status and Emerging PrioritiesPaul A White, Alexandra S Long, George E Johnson
Plos Neglected Tropical Diseases|September 4, 2015
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous LeishmaniasisEmily Rose Mears, Farrokh Modabber, Robert Don, et al.
Mutation Research. Reviews in Mutation Research|August 19, 2015
Theoretical considerations for thresholds in chemical carcinogenesisAdam D Thomas, Jörg Fahrer, George E Johnson, et al.
Archives of Toxicology|May 18, 2019
Correction to: Re: Gi et al. 2018, In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats, Archives of Toxicology 92:3207-3221Paul A White, Andreas Zeller, Stefan Pfuhler, et al.
Archives of Toxicology|February 13, 2025
A benchmark concentration-based strategy for evaluating the combined effects of genotoxic compounds in TK6 cellsJulie Sanders, Roel Anthonissen, George E Johnson, et al.
Mutagenesis|March 4, 2010
Metabolic influences for mutation induction curves after exposure to Sudan-1 and para redGeorge E Johnson, Emma L Quick, Elizabeth M Parry, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 8, 2015
Correlation of In Vivo Versus In Vitro Benchmark Doses (BMDs) Derived From Micronucleus Test Data: A Proof of Concept StudyLya G Soeteman-Hernández, Mick D Fellows, George E Johnson, et al.
Mutation Research|August 12, 2009
Vinblastine and diethylstilboestrol tested in the in vitro mammalian cell micronucleus test (MNvit) at Swansea University UK in support of OECD draft Test Guideline 487George E Johnson, Gareth J Jenkins, Adam D Thomas, et al.
Regulatory Toxicology and Pharmacology : RTP|December 10, 2020
A weight of evidence assessment of the genotoxicity of 2,6-xylidine based on existing and new data, with relevance to safety of lidocaine exposureDavid J Kirkland, Meredith L Sheil, Michael A Streicker, et al.
Toxicology|November 26, 2009
Genotoxic thresholds, DNA repair, and susceptibility in human populationsGareth J S Jenkins, Zoulikha Zaïr, George E Johnson, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Environmental and Molecular Mutagenesis|December 4, 2019
Quantitative Interpretation of Genetic Toxicity Dose-Response Data for Risk Assessment and Regulatory Decision-Making: Current Status and Emerging PrioritiesPaul A White, Alexandra S Long, George E Johnson
Plos Neglected Tropical Diseases|September 4, 2015
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous LeishmaniasisEmily Rose Mears, Farrokh Modabber, Robert Don, et al.
Mutation Research. Reviews in Mutation Research|August 19, 2015
Theoretical considerations for thresholds in chemical carcinogenesisAdam D Thomas, Jörg Fahrer, George E Johnson, et al.
Archives of Toxicology|May 18, 2019
Correction to: Re: Gi et al. 2018, In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats, Archives of Toxicology 92:3207-3221Paul A White, Andreas Zeller, Stefan Pfuhler, et al.
Archives of Toxicology|February 13, 2025
A benchmark concentration-based strategy for evaluating the combined effects of genotoxic compounds in TK6 cellsJulie Sanders, Roel Anthonissen, George E Johnson, et al.
Mutagenesis|March 4, 2010
Metabolic influences for mutation induction curves after exposure to Sudan-1 and para redGeorge E Johnson, Emma L Quick, Elizabeth M Parry, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 8, 2015
Correlation of In Vivo Versus In Vitro Benchmark Doses (BMDs) Derived From Micronucleus Test Data: A Proof of Concept StudyLya G Soeteman-Hernández, Mick D Fellows, George E Johnson, et al.
Mutation Research|August 12, 2009
Vinblastine and diethylstilboestrol tested in the in vitro mammalian cell micronucleus test (MNvit) at Swansea University UK in support of OECD draft Test Guideline 487George E Johnson, Gareth J Jenkins, Adam D Thomas, et al.
Regulatory Toxicology and Pharmacology : RTP|December 10, 2020
A weight of evidence assessment of the genotoxicity of 2,6-xylidine based on existing and new data, with relevance to safety of lidocaine exposureDavid J Kirkland, Meredith L Sheil, Michael A Streicker, et al.
Toxicology|November 26, 2009
Genotoxic thresholds, DNA repair, and susceptibility in human populationsGareth J S Jenkins, Zoulikha Zaïr, George E Johnson, et al.
Pageof 7